Form 4: Compass Pathways Director Thomas Lonngren Reports Share Option Grant

Director Thomas Lonngren reports acquisition of share options in Compass Pathways plc.

Summary

• Thomas Lonngren, a director of COMPASS Pathways plc, reported a transaction involving derivative securities.
• On May 9, 2024, Lonngren acquired 26,000 share options with an exercise price of $8.54.
• These options vest in full upon the earlier of the first anniversary of the grant date or the date of COMPASS Pathways plc's Annual General Meeting of Shareholders in 2025.
• The options expire on May 8, 2034.
• Following the transaction, Lonngren directly owns 26,000 derivative securities.
• The ordinary shares may be represented by American Depositary Shares, each representing one ordinary share.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, indicating standard compensation practices. It doesn't contain information that would significantly sway investor sentiment positively or negatively.

Positives

• The grant of share options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes the director to contribute to the company's success over the long term.

Industry Context

Share option grants are a common practice in the pharmaceutical and biotechnology industries to incentivize executives and align their interests with shareholders, particularly in companies focused on research and development.

Comparison to Industry Standards

• Share option grants are a standard component of executive compensation packages in the biotech industry.
• Companies like MindMed and Atai Life Sciences also utilize stock options to incentivize their leadership teams.
• The vesting schedule and exercise price are typical for such grants, aligning with industry norms for long-term incentive plans.

Stakeholder Impact

• The grant of share options could have a slightly positive impact on shareholders by aligning the director's interests with the company's long-term success.

Key Dates